Cellular Vehicles for Cancer Gene Therapy
- 1 January 2004
- journal article
- Published by Springer Nature in BioDrugs
- Vol. 18 (6) , 361-385
- https://doi.org/10.2165/00063030-200418060-00003
Abstract
No abstract availableKeywords
This publication has 100 references indexed in Scilit:
- Therapeutic stem and progenitor cell transplantation for organ vascularization and regenerationNature Medicine, 2003
- Progress and problems with the use of viral vectors for gene therapyNature Reviews Genetics, 2003
- Bone marrow-derived, endothelial progenitor-like cells as angiogenesis-selective gene-targeting vectorsGene Therapy, 2003
- The role of tumour‐associated macrophages in tumour progression: implications for new anticancer therapiesThe Journal of Pathology, 2002
- Hypoxia — a key regulatory factor in tumour growthNature Reviews Cancer, 2002
- Generation of high-titer retroviral vector-producing macrophages as vehicles for in vivo gene transferGene Therapy, 2001
- Genetically modified CD34+ cells as cellular vehicles for gene delivery into areas of angiogenesis in a rhesus modelGene Therapy, 2000
- Development of engineered cells for implantation in gene therapyAdvanced Drug Delivery Reviews, 1998
- Fate of mouse macrophages radiolabelled with PKH-95 and injected intravenouslyNuclear Medicine and Biology, 1995
- A Progress Report on the Treatment of 157 Patients with Advanced Cancer Using Lymphokine-Activated Killer Cells and Interleukin-2 or High-Dose Interleukin-2 AloneNew England Journal of Medicine, 1987